You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell vaccine

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Poliomyelitis Trial in Pizhou (Investigational sIPV, Control IPV)

Completed
  • Poliomyelitis
  • Investigational sIPV
  • Control IPV
  • Pizhou, Jiangsu, China
    Pizhou County Center for Disease Control and Prevention
Jan 22, 2019

B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

Not yet recruiting
  • B-cell Malignancy
  • +7 more
  • (no location specified)
Oct 26, 2022

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Cerebral Adrenoleukodystrophy Trial in Minneapolis (Mesenchymal stem cells (IV-MSC))

Recruiting
  • Cerebral Adrenoleukodystrophy
  • Mesenchymal stem cells (IV-MSC)
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Sep 7, 2023

NSCLC Trial in United States (bevacizumab, Erlotinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Galloway, New Jersey
  • +6 more
Jun 17, 2022

Head and Neck Squamous Cell Carcinoma Trial in Tucson, San Francisco (Ruxolitinib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Tucson, Arizona
  • +1 more
Sep 22, 2022

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Advanced Renal Cell Carcinoma Trial (Botensilimab, Balstilimab, Ipilimumab)

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 23, 2023

Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)

Recruiting
  • Head and Neck Squamous Cell Carcinomas
  • Guanzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 28, 2022

NSCLC Trial in Pierre-Benite (Cisplatin-Gemzar, Cisplatin-Navelbine-Radiotherapy, Carboplatin-Taxol-Radiotherapy)

Completed
  • Non-small Cell Lung Cancer
  • Pierre-Benite, France
    Centre Hospitalier Lyon-Sud - Radiotherapie/Oncologie
May 23, 2019

Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

Completed
Has Results
  • Cancer of Kidney
  • +6 more
  • 124-Iodine-cG250 (124I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Diabetes, Type 2, Endothelial Dysfunction Trial in Boston (Dapagliflozin, Placebo)

Recruiting
  • Diabetes Mellitus, Type 2
  • Endothelial Dysfunction
  • Boston, Massachusetts
    BU School of Medicine Evans 748
Jun 1, 2022

Educational Problems Trial in Sakarya (Gamification method group, Flipped learning group)

Completed
  • Educational Problems
  • Gamification method group
  • Flipped learning group
  • Sakarya, Turkey
    Sakarya University
Feb 1, 2023

Chemo-induced Nausea and Vomiting Trial in Istanbul (Breathing exercise group, Control group)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Breathing exercise group
  • Control group
  • Istanbul, Turkey
    Koç University Hospital
Apr 6, 2022

Metastatic Non Small Cell Lung Cancer Trial in Japan (Datopotamab Deruxtecan, Pembrolizumab, Pemetrexed)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Datopotamab Deruxtecan
  • +4 more
  • Fukuoka, Japan
  • +3 more
Jan 13, 2023

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +20 more
Dec 15, 2022

COVID-19 Vaccine Knowledge, COVID-19 Vaccine Beliefs Trial in Stanford (COVID-19 Vaccine IVR Training, Control Condition)

Completed
  • COVID-19 Vaccine Knowledge
  • COVID-19 Vaccine Beliefs
  • COVID-19 Vaccine IVR Training
  • Control Condition
  • Stanford, California
    Stanford University
Feb 17, 2022

Fumarate Hydratase Deficient Renal Cell Carcinoma Trial (Tislelizumab, Lenvatinib)

Not yet recruiting
  • Fumarate Hydratase Deficient Renal Cell Carcinoma
  • (no location specified)
May 18, 2023

NSCLC Trial in Worldwide (Amivantamab, Pemetrexed, Carboplatin)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Duarte, California
  • +228 more
Jan 31, 2023

Sickle Cell Disease Trial in Paris (oxygen therapy)

Completed
  • Sickle Cell Disease
  • oxygen therapy
  • Paris, France
    Hôpital Necker Enfants-Malades (Public Hospitals of Paris)
Nov 4, 2022

Metastatic Non Small Cell Lung Cancer Trial in Italy (Tedopi, Nivolumab, Docetaxel)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Meldola, Forlì, Italy
  • +11 more
Feb 9, 2022

HPV Infection Trial in Mianyang (Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris))

Active, not recruiting
  • HPV Infection
  • Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)
  • Mianyang, Sichuan, China
    Mianyang Center for Disease Control and Prevention
Jul 7, 2021

Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

Available
  • Neuroblastoma
  • Childhood Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
  • 131 I-MIBG
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 11, 2022

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jun 9, 2022

Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic

Active, not recruiting
Has Results
  • Advanced Non Small Cell Lung Cancer
  • Advanced (Inoperable) Non Small Cell Lung Cancer
  • Pharmacokinetic sampling
  • +2 more
  • San Diego, California
  • +15 more
Feb 21, 2022